Sponsored Videos

Nageswara Kollu, Senior Director at Apellis Pharmaceuticals, explains how the discovery team leverages AI to automate preclinical documentation and regulatory filings, improving consistency and achieving significant time savings in the drug development process.

Corey Collins, CEO of Tekton Research, and Taryn Collett, COO of Tekton Research, discuss how Tekton's approach and collaboration with others is speeding up disease research.

Steve Rosenberg, CEO of uMotif, explores the core challenges of clinical trial recruitment and retention, and discusses how digital tools empower sites and patients to build more effective, trust-based relationships.

Gain insights into the operational challenges facing clinical research sites today, learn what sponsors and CROs can do to reduce burden, and explore how evolving collaboration models and technology will shape clinical trials over the next five years.

Explore the challenges sponsors and CROs face in maintaining clinical reference data, uncover the hidden costs of traditional upkeep models, and see how integrated data solutions can streamline operations across the clinical ecosystem.

Explore how Dash Solutions is transforming clinical trial payments through its dashClinical platform, improving site efficiency, participant engagement, and overall trial management in this conversation with Katie Anne Oden, VP, sales, at the 2025 SCRS Global Site Solutions Summit.

Discover how evolving clinical trial trends are reshaping patient and site experiences—and the steps sponsors can take to stay ahead—in this conversation with uMotif CEO Steve Rosenberg at SCOPE Summit 2025.

David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.

Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research organization (CRO) partners to support clinical trials that are patient-first and accessible.

Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.

Jenny Denney, EVP, Head of FSP Clinical and Biometrics at Parexel, discusses current transformations in the industry in addition to how Parexel, as the landscape shifts, supports clients with proper models and infrastructure from a functional service provider (FSP) perspective.

Jon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.

Jason Gagner (Vice President of Product for Life Science, PurpleLab) talks about clinical trial variables and how PurpleLab is working to maintain patient retention and accelerate site feasibility.

In these videos, Matthew Gordon from Parexel International explores the challenges and benefits that go hand in hand with implementing real-world evidence (RWE) innovations.

In this video, Dr Loren Blake (Study Director, FSP Solutions) and Jack Bradley (Executive Director) from LabConnect share their keen insights on the challenges that sponsors currently face in clinical trials, as well as ways to overcome them to accelerate outcomes.

Cat Hall, Vice President of Data and Quality, endpoint Clinical, provides insight on managing Interactive Response Technology audit data to avoid delays, ensure regulatory compliance and maintain data integrity for trial success.

Sonja Wustrack, OM1, highlights a new clinical study automation platform to support critical data collection and real-world evidence.

Esther Howard, Oncology Advisor at THREAD, will be shedding light on how DCT design brings clinical research as a care option to cancer patients. In 2021, over 608,000 Americans alone passed away from cancer- equating to 1,600 deaths a day. Because clinical trials become the only treatment option for cancer patients after they have exhausted all standard of care options, we desperately need solutions to bring real access to clinical trials as a care option to more cancer patients. Esther will focus on some of the challenges that patients face, and how elements of a DCT design can not only save the lives of more patients but can also be a key driver in improving diversity in enrollment.

Watch our roundtable participants discuss the Next Best in Patient Centricity, with topics including the meaning of patient centricity; how to increase patient engagement in clinical trials; data and technology; and the site perspective.

Nagaraja Srivatsan, SVP & Chief Digital Officer at IQVIA, breaks down the most recent challenges in the decentralized trial space: patient burden, the ecosystem between the patient and information, and the global regulatory landscape.

Almac provides an overview of their clinical technologies branch, their IRT offerings, and the current changes to the clinical development industry.

YPrime President, Mark Maietta, discusses the future of decentralized clinical trials following Covid-19. Adaptations will need to be made as DCT is here to stay.